Viewing Study NCT00521261


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2026-01-31 @ 7:39 AM
Study NCT ID: NCT00521261
Status: WITHDRAWN
Last Update Posted: 2014-03-05
First Post: 2007-08-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Sponsor: Barbara Ann Karmanos Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult Burkitt lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent mantle cell lymphoma View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None Waldenstrom macroglobulinemia View
None adult nasal type extranodal NK/T-cell lymphoma View
None recurrent adult grade III lymphomatoid granulomatosis View
None cutaneous B-cell non-Hodgkin lymphoma View